{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T05:10:45Z","timestamp":1722402645305},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"40","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Anorexia is a common cause of malnutrition and is associated with negative effects on the quality of life (QOL) for patients with cancer. Management of appetite is the key to improving both the QOL and the prognosis for such patients. Yukgunja-tang (YGJT) is a traditional herbal medicine extensively prescribed in Korea as a remedy for various gastrointestinal syndromes. Currently, no standardized herbal medicine treatment exists for patients with cancer who are suffering from anorexia after surgery, chemotherapy, and\/or radiotherapy. For that reason, this study aims to examine the efficacy and the safety of using YGJT to treat anorexia in such patients and to establish whether or not YGJT can be recommended as the primary therapy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We will enroll 52 cancer patients diagnosed with anorexia. The enrolled participants will be randomly allocated to 2 groups: The control group will receive nutrition counseling, and the YGJT group will receive nutrition counseling and be administered YGJT at a dose of 3\u200ag twice a day for 4 weeks (a total of 56 doses of 3.0\u200ag per dose). The primary outcome of this study is the change in the score on the anorexia\/cachexia subscale (A\/CS) of the Functional Assessment of Anorexia\/Cachexia Therapy (FAACT). The secondary outcomes are the changes in the FAACT score with the A\/CS score excluded, the score on the Visual Analogue Scale (VAS) for appetite, the weight and the body mass index (BMI), and laboratory tests for compounds such as leptin, tumor necrosis factor-\u03b1 (TNF-\u03b1), ghrelin, and IL-6. All variables related to the safety assessment, such as vital signs, electrocardiography results, laboratory test results (CBC, chemistry, urine test), and adverse events, will be documented on the case report form (CRF) at every visit.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>This study is the first randomized controlled trial to investigate the efficacy and the safety of using YGJT for treating patients with cancer-related anorexia in Korea. We designed this study based on previous research about YGJT. This study will serve as a pilot and provide data for planning further clinical trials on herbal medicine and cancer-related anorexia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration:<\/jats:title>\n            <jats:p>Clinical Research Information Service (CRIS), Republic of Korea, ID: KCT0002847. Registered retrospectively on 3 April 2018.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000016950","type":"journal-article","created":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T15:13:51Z","timestamp":1570029231000},"page":"e16950","source":"Crossref","is-referenced-by-count":7,"title":["Efficacy and safety of Yukgunja-Tang for treating anorexia in patients with cancer"],"prefix":"10.1097","volume":"98","author":[{"given":"Hwi-Joong","family":"Kang","sequence":"first","affiliation":[{"name":"East-West Cancer Center, Dunsan Korean Medicine Hospital of Daejeon University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi-Kyung","family":"Jeong","sequence":"additional","affiliation":[{"name":"Clinical Medicine Division, Korea Institute of Oriental Medicine, Daejeon, Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"So-Jung","family":"Park","sequence":"additional","affiliation":[{"name":"East-West Cancer Center, Dunsan Korean Medicine Hospital of Daejeon University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyeong-Joon","family":"Jun","sequence":"additional","affiliation":[{"name":"East-West Cancer Center, Dunsan Korean Medicine Hospital of Daejeon University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hwa-Seung","family":"Yoo","sequence":"additional","affiliation":[{"name":"East-West Cancer Center, Dunsan Korean Medicine Hospital of Daejeon University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2019,10]]},"reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1188\/09.CJON.95-102","article-title":"Putting evidence into practice: evidence-based interventions to prevent and manage anorexia","volume":"13","author":"Adams","year":"2009","journal-title":"Clin J Oncol Nurs"},{"key":"R2-20230915","first-page":"499","article-title":"Pharmacologic therapy for the cancer anorexia\/weight loss syndrome: a data-driven, practical approach","volume":"4","author":"Jatoi","year":"2006","journal-title":"J Support Oncol"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/sj.bjc.6605578","article-title":"Prevalence, risk factors and clinical implications of malnutrition in French Comprehensive Cancer Centres","volume":"102","author":"Pressoir","year":"2010","journal-title":"Br J Cancer"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.nut.2009.04.013","article-title":"Prevalence and risk factors of malnutrition among cancer patients according to tumor location and stage in the National Cancer Center in Korea","volume":"26","author":"Wie","year":"2010","journal-title":"Nutrition"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0149-2918(05)80001-3","article-title":"Prognostic effect of weight loss prior tochemotherapy in cancer patients","volume":"69","author":"Dewys","year":"1980","journal-title":"Am J Med"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"e229","DOI":"10.14694\/EdBook_AM.2015.35.e229","article-title":"Current and future care of patients with the cancer anorexia-cachexia syndrome","author":"Del Fabbro","year":"2015","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1038\/sj.bjc.6601090","article-title":"Standards, options and recommendations for the use of appetite stimulants in oncology","volume":"89","author":"Desport","year":"2003","journal-title":"Br J Cancer"},{"key":"R9-20230915","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2165\/00003495-199855050-00005","article-title":"A review of the drug treatment of cachexia associated with cancer","volume":"55","author":"Gagnon","year":"1998","journal-title":"Drugs"},{"key":"R11-20230915","doi-asserted-by":"crossref","first-page":"4819","DOI":"10.2174\/138161212803216979","article-title":"The use of herbal medicine in cancer-related anorexia\/cachexia treatment around the world","volume":"18","author":"Cheng","year":"2012","journal-title":"Curr Pharm Des"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-2036.1993.tb00120.x","article-title":"Effect of treatment with Liu-Jun-Zi-Tang (TJ-43) on gastric emptying and gastrointestinal symptoms in dyspeptic patients","volume":"7","author":"Tatsuta","year":"1993","journal-title":"Aliment Pharmacol Ther"},{"key":"R13-20230915","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/j.1365-2982.2009.01290.x","article-title":"Japanese herbal medicine in functional gastrointestinal disorders","volume":"21","author":"Suzuki","year":"2009","journal-title":"Neurogastroenterol Motility"},{"key":"R14-20230915","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s00535-011-0488-5","article-title":"Rikkunshito improves symptoms in PPI-refractory GERD patients: a prospective, randomized, multicenter trial in Japan","volume":"47","author":"Tominaga","year":"2012","journal-title":"J Gastroenterol"},{"key":"R15-20230915","doi-asserted-by":"crossref","first-page":"936459","DOI":"10.1155\/2012\/936459","article-title":"Chinese herbal medicine liu jun zi tang and xiang sha liu jun zi tang for functional dyspepsia: meta-analysis of randomized controlled trials","volume":"2012","author":"Xiao","year":"2012","journal-title":"Evid Based Complement Alternat Med"},{"key":"R16-20230915","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/519035","article-title":"Beneficial effects of rikkunshito, a Japanese kampo medicine, on gastrointestinal dysfunction and anorexia in combination with Western drug: a systematic review","volume":"2014","author":"Mogami","year":"2014","journal-title":"Evid Based Complement Alternat Med"},{"key":"R17-20230915","doi-asserted-by":"crossref","first-page":"364260","DOI":"10.1155\/2015\/364260","article-title":"A new strategy using rikkunshito to treat anorexia and gastrointestinal dysfunction","volume":"2015","author":"Saegusa","year":"2015","journal-title":"Evid Based Complement Alternat Med"},{"key":"R18-20230915","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00535-016-1227-8","article-title":"Evidence-based clinical practice guidelines for gastroesophageal reflux disease","volume":"51","author":"Iwakiri","year":"2016","journal-title":"J Gastroenterol"},{"key":"R19-20230915","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1053\/j.gastro.2008.02.078","article-title":"Rikkunshito, an herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2 receptor antagonism","volume":"134","author":"Takeda","year":"2008","journal-title":"Gastroenterology"},{"key":"R20-20230915","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.regpep.2010.02.003","article-title":"Rikkunshito and 5-HT2C receptor antagonist improve cisplatin-induced anorexia via hypothalamic ghrelin interaction","volume":"161","author":"Yakabi","year":"2010","journal-title":"Regul Pept"},{"key":"R21-20230915","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2147\/CEG.S26297","article-title":"Rikkunshito, a traditional Japanese medicine, suppresses cisplatin-induced anorexia in humans","volume":"4","author":"Ohno","year":"2011","journal-title":"Clin Exp Gastroenterol"},{"key":"R22-20230915","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s00520-003-0568-z","article-title":"Cancer: disease and nutrition are key determinants of patients\u2019 quality of life","volume":"12","author":"Ravasco","year":"2004","journal-title":"Support Care Cancer"},{"key":"R23-20230915","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.clnu.2007.01.005","article-title":"Nutritional intervention and quality of life in adult oncology patients","volume":"26","author":"Mar\u00edn Caro","year":"2007","journal-title":"Clin Nutr"},{"key":"R24-20230915","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00520-016-3455-0","article-title":"Effects of a multimodal rehabilitation programme on inflammation and oxidative stress in oesophageal cancer survivors: the ReStOre feasibility study","volume":"25","author":"Guinan","year":"2017","journal-title":"Support Care Cancer"},{"key":"R25-20230915","first-page":"557","article-title":"The effect of individual nutrition counseling on diet and nutrition status of postoperative breast cancer patients","volume":"37","author":"Do Min","year":"2004","journal-title":"J Nutr Health"},{"key":"R26-20230915","doi-asserted-by":"crossref","first-page":"59","DOI":"10.14373\/JKDA.2012.18.1.059","article-title":"Patient perceptions of clinical nutrition service","volume":"18","author":"Choi","year":"2012","journal-title":"J Korean Dietetic Assoc"},{"key":"R27-20230915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/8780325","article-title":"Efficacy and safety of sipjeondaebo-tang for anorexia in patients with cancer: a pilot, randomized, double-blind, placebo-controlled trial","volume":"2017","author":"Cheon","year":"2017","journal-title":"Evid Based Complementary Alternat Med"},{"key":"R28-20230915","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s00535-009-0166-z","article-title":"The traditional Japanese medicine Rikkunshito increases the plasma level of ghrelin in humans and mice","volume":"45","author":"Matsumura","year":"2010","journal-title":"J Gastroenterol"},{"key":"R29-20230915","first-page":"62","article-title":"Rikkunshito improves the symptoms in patients with functional dyspepsia, accompanied by an increase in the level of plasma ghrelin","volume":"59","author":"Arai","year":"2012","journal-title":"Hepatogastroenterology"},{"key":"R30-20230915","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3389\/fphar.2014.00271","article-title":"Rikkunshito, a ghrelin potentiator, ameliorates anorexia-cachexia syndrome","volume":"5","author":"Fujitsuka","year":"2014","journal-title":"Front Pharmacol"},{"key":"R31-20230915","article-title":"A new candidate supporting drug, rikkunshito, for the QOL in advanced esophageal cancer patients with chemotherapy using docetaxel\/5-FU\/CDDP","volume":"2011","author":"Seike","year":"2011","journal-title":"Int J Surg Oncol"},{"key":"R32-20230915","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.biopsych.2008.10.031","article-title":"Selective serotonin reuptake inhibitors modify physiological gastrointestinal motor activities via 5-HT2c receptor and acyl ghrelin","volume":"65","author":"Fujitsuka","year":"2009","journal-title":"Biol Psychiatry"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000016950","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T21:44:06Z","timestamp":1694814246000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000016950"}},"subtitle":["The protocol for a pilot, randomized, controlled trial"],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":30,"journal-issue":{"issue":"40","published-online":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000016950","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10]]}}}